Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Rat IL-10 ELISA Test Kit

Product Description
The MaxDiscovery™ Rat IL-10 ELISA Test Kit is designed for quantitative determination of the concentration of rat IL-10 in serum, plasma, and cell culture supernatant. Mature rat Interleukin-10 (IL-10), also referred to as cytokine synthesis inhibitory factor (CSIF), is an ~18 kDa protein of 160 amino acids (aa) after cleavage of an 18 aa signal peptide. There are two potential N-linked glycosylation sites and five cysteine residues in the mature molecule. Four of its five cysteine residues are involved in the formation of two intrachain disulfide linkages that are essential for activity. Based on human and murine studies, biologically active rat interleukin-10 is likely to be a nondisulfide-linked homodimer in solution. IL-10 has pleiotropic effects in immunoregulation and inflammation. It is produced primarily by monocytes and to a lesser extent by lymphocytes. IL-10 down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-?B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Rat IL-10 shares 85% aa sequence identity with mouse IL-10 and 74% aa sequence identity with human IL-10. Rat and human IL-10 are both active on mouse cells, however; mouse IL-10 is not active on human cells.
Product MaxDiscovery™ Rat IL-10 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2206-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos